Breast Cancer Clinical Trial
Official title:
A Randomized Controlled Comparison of PECI/SPB Versus Intercostal Nerve Block for the Management of Postoperative Pain in Latissimus Dorsi Flap Reconstruction
Regional Anesthesia is a procedure in which numbing medication is injected around nerves
that transmit pain from areas involved in a surgery. The objective is to block the nerves so
a patient does not feel pain after surgery. Regional nerve blocks offer many advantages over
traditional anesthetic techniques, including faster recovery time, fewer side effects and a
dramatic reduction in post-surgical pain.
The use of regional anesthesia in breast reconstructive surgery, such as the latissimus
dorsi flap, has led to major improvements in patient care. Today, the most common regional
anesthetic used in latissimus dorsi flap reconstruction is the intercostal nerve block,
where numbing medication is injected around the nerves supplying the chest wall.
While intercostal nerve blocks have been used successfully in breast surgery, they do not
provide a complete nerve block to the chest wall, as there are some nerves that are
unaccounted for in the block which can contribute to a patients pain after surgery.
The mixed pectoral one / serratus plane block (PECI/SPB) block is another regional nerve
block that has been successfully used by anesthesiologists at The Ottawa Hospital and offers
a more complete pain blockade than the intercostal nerve block, as it includes more nerves
that supply the breast. In addition to this, the intercostal nerve block is a so-called
"blind-technique" compared to the PECI/SPB block, which is more accurately guided by
ultrasound. Blind techniques are associated with higher failure rates.
Both the intercostal nerve block and the PECI/SPB nerve block have been used successfully at
the Ottawa Hospital. In this study, the investigators propose a prospective, double blinded,
randomized controlled, head to head comparison of the PECI/SPB and intercostal nerve block
to determine which block is associated with the best pain blockade and patient satisfaction
in lattissimus dorsi flap surgery.
Recent literature has unequivocally demonstrated that postoperative pain remains
under-treated in hospitals. While breast surgery remains one of the most common surgeries
performed in hospitals today, it has been shown that 40% of women still experience
meaningful pain postoperatively. It is well known that poor pain control is not only
associated with slower recovery, longer admission in hospital and poor patient satisfaction
but it also can lead to the development of chronic post surgical pain.
In recent years, regional nerve blocks have emerged as a promising adjunct to standard
postoperative analgesic ladder protocols. The main advantage of regional anesthesia is the
reduction of postoperative pain while limiting the amount of oral and intravenous narcotic
use. The reduction of postoperative narcotic use is advantageous for the patient and
caregiver alike as it reduces common side effects associated with such medications, such as
drowsiness, nausea, vomiting, upset stomach and dizziness.
Regional anesthesia in breast reconstruction surgery commonly include thoracic epidurals,
intercostal nerve blocks and paravertebal nerve blocks. To date, there remains no standard
of care for perioperative pain management and it is usually left to the discretion of the
surgeon and anesthesiologist involved to decide which pain blockade is preferable on a case
by case basis. While paravertebral and intercostal nerve blocks have shown promising
results, they do not provide a complete sensory block to the anterior chest wall, as
innervation is supplied not only from the thoracic spinal nerves but also via medial and
lateral pectoral nerves off the brachial plexus.
The pectoral nerve block is a novel interfascial block placed into the plane between
pectoralis major and minor muscles and is particularly useful in reconstructive breast
surgery involving subpectoral prosthesis. It has been associated with minimal analgesia
postoperatively and is thought to be particularly useful in the daycare setting.
To the best of the knowledge of the investigators, the utility of the pectoral nerve block
in pedicled Latissimus Dorsi breast reconstruction has not been investigated. A mixed PEC I/
Serratus Plane Block provides analgesia to the lateral and medial pectoral nerves, lateral
and anterior branches of the T2-T4 spinal nerves, long thoracic nerve and thoracodorsal
nerve, theoretically offering a more comprehensive block than the midaxillary intercostal
block and with no additional morbidity to the patient. Furthermore, the intercostal nerve
block is a blind technique that may be associated with higher failure rates compared to the
more precise, ultrasound guided, PECI/SPB block.
In this study, the investigators plan to systematically investigate these two blocks in
latissimus dorsi flap reconstruction in order to document optimal postoperative pain
management.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |